King's College London

Research portal

Cancer Gene Therapy, ‎0929-1903

Journal

  1. A modified human Myogenin promoter that is highly active in alveolar rhabdomyosarcoma

    Pruller, J., Hofer, I., Ganassi, M., Heher, P., Ma, M. T. & Zammit, P. S., 1 Jan 2020, (Accepted/In press) In: Cancer Gene Therapy.

    Research output: Contribution to journalArticlepeer-review

  2. VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans

    Kazemi, M., Carrer, A., Moimas, S., Zandonà, L., Bussani, R., Casagranda, B., Palmisano, S., Prelazzi, P., Giacca, M., Zentilin, L., De Manzini, N., Giacca, M. & Zacchigna, S., 1 May 2016, In: Cancer Gene Therapy. 23, 5, p. 125-132 8 p.

    Research output: Contribution to journalArticlepeer-review

  3. Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report

    Norris, J. S., Bielawska, A., Day, T., El-Zawahri, A., Elojeimy, S., Hannun, Y., Holman, D., Hyer, M., Landon, C., Lowe, S., Dong, J. Y., McKillop, J., Norris, K., Obeid, L., Rubinchik, S., Tavassoli, M., Tomlinson, S., Voelkel-Johnson, C. & Liu, X., 14 Dec 2006, In: Cancer Gene Therapy. 13, 12, p. 1045 - 1051 7 p.

    Research output: Contribution to journalLiterature reviewpeer-review

  4. Role of 4-1BB : 4-1BB ligand in cancer immunotherapy

    Cheuk, A. T. C., Mufti, G. J. & Guinn, B. A., Mar 2004, In: Cancer Gene Therapy. 11, 3, p. 215 - 226 12 p.

    Research output: Contribution to journalArticlepeer-review

  5. E1A induces PML expression and apoptosis in EGFR over-expressing SCC cell lines.

    Tavassoli, M., Flinterman, M. & Gaken, J., 2004, In: Cancer Gene Therapy. 11, 12, p. P29

    Research output: Contribution to journalMeeting abstract

  6. Isolation of retinoic acid resistant HL-60 mutants using retroviral insertional mutagenesis

    Gan, S. U., Gaken, J., Hui, K. M. & Farzaneh, F., 2004, In: Cancer Gene Therapy. 11, 12, p. P9

    Research output: Contribution to journalMeeting abstract

  7. Monocistronic high titre vectors for targeted expression of multiple therapeutic genes

    Darling, D., Gaken, J., Nesbeth, D., Chan, L., Hardwick, N., Mackey, T., Galea-Lauri, J., Vyakarnam, A., Mufti, G., Kemeny, M. & Farzaneh, F., 2004, In: Cancer Gene Therapy. 11, 12, p. 843 - 843 1 p.

    Research output: Contribution to journalMeeting abstract

  8. Tumour specific induction of apoptosis by apoptin: Using DNA and protein

    Tavassoli, M., Guelen, L., Paterson, H., Gaken, J., Meyers, M. & Farzaneh, F., 2004, In: Cancer Gene Therapy. 11, 12, p. P28

    Research output: Contribution to journalMeeting abstract

  9. A new strategy for development of cytoplasmic fusagene vectors

    Hejazi, M. S., Gaken, J. & Farzaneh, F., 2001, In: Cancer Gene Therapy. 8, 11, p. 925 - 926 2 p.

    Research output: Contribution to journalMeeting abstract

  10. Affinity mediated magnetic concentration of retroviral vectors

    Hughes, C., Galea-Lauri, J., Farzanch, F. & Darling, D., 2001, In: Cancer Gene Therapy. 8, 11, p. 912 - 913 2 p.

    Research output: Contribution to journalMeeting abstract

  11. Challenges associated with adenovirus-mediated p53 gene transfer in a model of minimal residual cancer in the muscle bed

    Oakley, R. E., Phillips, E., Wilson, D. & Partridge, M., 2001, In: Cancer Gene Therapy. 8, 11, p. 919 - 919 1 p.

    Research output: Contribution to journalMeeting abstract

  12. Expression of wild-type p53 is required for p16/lNK4a to suppress cellular proliferation in head and neck cancer cells

    Tavassoli, M., Mashanyarne, D., Gaken, J., Littlewood, T. & Johnson, N., 2001, In: Cancer Gene Therapy. 8, 11, p. 920 - 920 1 p.

    Research output: Contribution to journalMeeting abstract

  13. Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron

    Gaken, J., Jiang, J., Daniel, K., van Berkel, E., Hughes, C., Kuiper, M., Darling, D., Tavassoli, M., Galea-Lauri, J., Ford, K., Kemeny, M., Russell, S. & Farzaneh, F., 2001, In: Cancer Gene Therapy. 8, 11, p. 913 - 913 1 p.

    Research output: Contribution to journalMeeting abstract

  14. Multiple furin recognition sequences enable more cleavage of the chimeric proteins encoded by the fusagene vectors

    Jiang, J., Gaken, J. & Farzaneh, F., 2001, In: Cancer Gene Therapy. 8, 11, p. 925 - 925 1 p.

    Research output: Contribution to journalMeeting abstract

  15. Rae-1 recognition by NKG2d: a molecular mechanism for gamma delta T-cell mediated surveillance of cutaneous malignancy in the mouse

    Oppenheim, D., Girardi, M., Steele, C., Lewis, J., Fuller, R., Gluscac, E., Hobby, P., Sutton, B., Tigelaar, R. & Hayday, A., 2001, In: Cancer Gene Therapy. 8, 11, p. 915 - 915 1 p.

    Research output: Contribution to journalMeeting abstract

  16. Local versus systemic interleukin-2: Tumor formation by wild-type and B7-1-positive murine melanoma cells

    Barnard, A. L., Farzaneh, F., Gaken, J. & Darling, D., 2000, In: Cancer Gene Therapy. 7, 2, p. 207 - 214 8 p.

    Research output: Contribution to journalArticlepeer-review

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454